Rival drugmakers want to upend Pfizer’s dominance of the $7 billion worldwide market for pneumonia vaccines
Rival drugmakers are seeking to upend Pfizer Inc.’s dominance of the $7 billion worldwide market for pneumonia vaccines, launching what is shaping up to be one of the industry’s fiercest battles.
Merck & Co. has already introduced a new competitor to Pfizer’s Prevnar vaccine franchise, while GSK PLC and Vaxcyte Inc. are among companies developing shots that aim to win sales by protecting against even more strains of the pneumonia virus.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
George Lopez squares off with daughter Mayan in 'Lopez vs. Lopez'Mayan Lopez remembers being 7 or 8 on the set of her father’s sitcom, “The George Lopez Show.” To earn extra money, she did odd jobs as an assistant director,
Lire la suite »
Jake Paul vs. Anderson Silva: YouTube superstar squares off against MMA legend in boxing matchJake Paul and Anderson Silva will be the main event in a catchweight boxing match Saturday night at the Gila River Arena in Glendale, Arizona.
Lire la suite »
Rising RSV respiratory virus hits kids hard, fills pediatric wards in Greater ClevelandUH Rainbow and Children’s Hospital is seeing double the number of children with RSV in their emergency department, compared with a month ago. And MetroHealth has seen a 500% increase in the past month.
Lire la suite »
Fully kicks off its November site-wide sale with 20 percent off everythingSome of our favorite standing desks are on sale.
Lire la suite »